NCT01202591
- Conditions
- Breast Diseases, Breast Neoplasms, ER+ Breast Cancer, +5 more
- Locations
-
- Research Site Leuven, Belgium
- Research Site Namur, Belgium
- Research Site Brno, Czechia
- Research Site Prague, Czechia
Clinical trial condition
FGFR Inhibition, Pharmacokinetics, Biomarkers
Explore clinical trials studying FGFR Inhibition, Pharmacokinetics, Biomarkers. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies